We introduce an infrared metasurface sensor based on plasmonic surface-enhanced infrared absorption spectroscopy combined with immunoassay, which detects alpha-synuclein, an early structural biomarker protein for neurodegenerative diseases with clinical specificity and identifies its different structural species using their unique spectroscopic signals. Unprecedentedly, we augmented the sensor with a Deep Neural Network, enabling quantitative differentiation of alpha-synuclein aggregates. Capable of multiplexing and retrieving aggregate signatures from complex biomatrix, our sensor shows promise for neurodegenerative disease diagnosis, disease progression monitoring, and drug efficacy assessment.
No takes yet. Share an insight, caveat, or question.
Kavungal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: